Explore Biotech Companies

Angiex develops antibody-based therapeutics, specifically first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) targeting cancer lethality and pathological angiogenesis.

📍 Cambridge, MA

Amylyx Pharmaceuticals is a clinical-stage biopharma company developing novel therapies for neurodegenerative diseases with high unmet needs.

📍 Cambridge, MA

AMSBIO is a leading transatlantic provider of life science reagents, lab tools, and custom services, specializing in cell culture and small molecules for research.

📍 Cambridge, MA

Amide Technologies is a biotech startup specializing in on-demand complex peptide manufacturing using its novel Automated Fast Flow Peptide Synthesis (AFPS) method developed at MIT.

📍 Cambridge, MA

Alnylam Pharmaceuticals is a biopharmaceutical company pioneering RNAi therapeutics for diseases like amyloidosis, hyperoxaluria, and porphyria.

📍 Cambridge, MA

Alltrna is the first tRNA platform company pioneering tRNA therapeutics to treat thousands of diseases by unlocking tRNA biology.

📍 Cambridge, MA

Alkeus Pharmaceuticals is a late-stage biopharmaceutical company focused on developing transformative therapies for progressive eye diseases, specializing in ophthalmics.

📍 Cambridge, MA

Alacrita is a biotech and pharma consulting firm offering strategic, clinical, and business development support, with expertise in drug development and enterprise building.

📍 Cambridge, MA

Akebia Therapeutics is a biopharmaceutical company focused on developing novel small molecule therapeutics for kidney disease.

📍 Cambridge, MA

Biotech company using computational chemistry and structural biology for precision therapies targeting hematologic cancers, including MPNs.

📍 Cambridge, MA

Aixa Bio democratizes genomics using generative AI for predictive modeling to improve healthspan.

📍 Cambridge, MA

Agios Pharmaceuticals is a biopharmaceutical company focused on small molecules for genetically defined diseases, pioneering therapies in cellular metabolism.

📍 Cambridge, MA

Aera Therapeutics is a biotech company focused on genetic medicine delivery using a proprietary protein nanoparticle (PNP) platform.

📍 Cambridge, MA

Abiologics pioneers Synteins™, a new class of supranatural and programmable biologics, aiming to transform disease treatment.

📍 Cambridge, MA

ProtaGene is a leading CRO providing advanced analytical solutions for biopharmaceutical and cell/gene therapy industries, from research to commercialization.

📍 Burlington, MA

PAQ Therapeutics pioneers autophagy-based KRAS degraders for lethal cancers lacking effective treatments.

📍 Burlington, MA

Median Technologies is a biotech company specializing in Imaging Phenomics, using AI for early cancer diagnosis, clinical trial imaging solutions, and medical image analysis.

📍 Burlington, MA

MapLight Therapeutics is a biotech company using optogenetics to develop circuit-specific treatments for brain disorders like ASD, Parkinson's, and Schizophrenia.

📍 Burlington, MA

LeMaitre Vascular is a global innovator and manufacturer of vascular surgical devices for treating peripheral vascular disease.

📍 Burlington, MA

Hyku Biosciences develops covalent medicines using a chemoproteomics platform that targets ligandable amino acids to inactivate disease-driving proteins.

📍 Burlington, MA

Fractyl Health is a clinical-stage biotech company developing thermal ablation and gene therapies to treat the root causes of metabolic diseases like obesity and type 2 diabetes.

📍 Burlington, MA

Chrysalis BioTherapeutics is a clinical-stage biotech company developing regenerative drugs. They utilize GMP space for manufacturing.

📍 Morrisville, NC

Ibex Medical Analytics provides AI-powered cancer diagnostics in pathology, transforming cancer diagnosis with its Galen platform.

📍 Brookline, MA

General Oncology is a clinical-stage biopharmaceutical company developing first-in-class medicines for metastatic and blood cancers, including a Phase 1 asset for BRCA-mutated pancreatic cancer.

📍 Brookline, MA